Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Grant/Award of 10,302 XNCR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Xencor Inc (XNCR) | Grant/Award | 10,302 | n/a |
| May 22, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Apr 17, 2026 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 100,000 | n/a |
| Mar 5, 2026 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 700,000 | n/a |
| Sep 19, 2025 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 300,000 | n/a |
| Jul 2, 2025 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Jun 16, 2025 | Xencor Inc (XNCR) | Grant/Award | 13,686 | n/a |
| Jan 23, 2025 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 40,400 | n/a |
| Sep 24, 2024 | TScan Therapeutics, Inc. (TCRX) | Purchase | 5,000 | $26.4K |
| Aug 27, 2024 | TScan Therapeutics, Inc. (TCRX) | Purchase | 5,000 | $28.5K |